Navigation Links
Roche Acquires RALS IT Connectivity Assets to Strengthen Presence in Point-of-Care Information Management

INDIANAPOLIS, Oct. 13 /PRNewswire-FirstCall/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) and Medical Automation Systems, Inc. (MAS) announced today that they have signed an agreement under which Roche will acquire certain assets from MAS, a Charlottesville, Virginia-based privately held company. Under the terms of the agreement, Roche will acquire all the assets associated with the RALS point-of-care (POC) information technology (IT) connectivity system, as well as the names "Medical Automation Systems," "MAS" and "RALS." As part of the transaction, Roche expects to retain substantially all of the MAS employees.

"As a global leader in POC testing, Roche is committed to helping improve the quality of patient care by providing products that support clinical decision-making," said Jack Phillips, president and CEO of Roche Diagnostics Corporation North America. "Information management plays an increasingly critical role to meet the growing needs of our POC customers. With this acquisition, we will build on our strategy to deliver integrated testing solutions to our customers."

MAS is the market leader in POC information management with the RALS POC IT connectivity system, used in over 2,000 hospitals in the United States (USA). MAS pioneered the use of IT systems to improve the efficiency and regulatory compliance of hospital POC programs. Over the past decade, MAS has consistently brought innovative functionality to the market through collaborative development with its diagnostic partners.  

"MAS and Roche have had a close partnership for over ten years to co-market RALS for hospital blood glucose testing in the US" said Kurt Wassenaar, chief executive officer of MAS. "Roche is the ideal company to build upon the RALS system and deliver the next generation of information management systems. We're very pleased that Roche has decided to acquire these assets and is committed to ensuring the continued success and support of the RALS products and pipeline."

Roche Diagnostics develops and commercializes innovative solutions in the field of serum-based laboratory and POC testing, including CoaguChek® and ACCU-CHEK® brand products used by healthcare professionals to monitor coagulation and blood glucose at the point of care. They are currently used with the RALS information management systems in healthcare facilities across the US.

"The acquisition of RALS assets is a perfect fit with our strategy to deliver market-leading IT connectivity solutions. It further complements our IT product portfolio," stated Peter Finckh, Head of Global Platforms and Support Roche Diagnostics. "With this acquisition, we gain a very talented group of people with strong expertise and domain knowledge in POC IT, which we expect to be instrumental in delivering future generations of POC -IT solutions in collaboration with existing forces. It will further enable our mission to provide leading integrated testing solutions for our customers."

As part of Roche, RALS will remain a vendor-neutral IT connectivity solution and Roche will continue to expand the number of device interfaces available, enabling customers to streamline POC management in their hospitals.  

This transaction is subject to customary closing conditions. Upon closing, the legal entity currently known as MAS will be renamed.

About MASMAS, a leading provider of POC information management systems, is based in Charlottesville, Virginia, USA.  In addition to the RALS system, MAS provides informatics solutions for critical care applications including inpatient IV insulin dosing software and ICU outcomes reporting software, as well as analytical services.  

About RocheHeadquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2009, Roche had over 80,000 employees worldwide and invested almost 10 billion Swiss francs in R&D. The Group posted sales of 49.1 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: or

All trademarks used or mentioned in this release are protected by law.For further information, please contact: Betsy CoxDirector, Corporate CommunicationsRoche Diagnostics CorporationIndianapolis, IN(317)

SOURCE Roche Diagnostics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
3. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
4. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
5. Roche Announces Positive Results in Solid Tumors Using Human Monoclonal Antibody Against IGF-1R (R1507)
6. Roche Diagnostics HIV Viral Load Test Used in Clinical Trials for Isentress, a New Class of HIV Drug
7. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
8. Two Pivotal Phase III Studies for Roches ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms
9. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
10. Roche responds to announcement of IDEAL hepatitis C trial results
11. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
Post Your Comments:
(Date:10/13/2015)... 2015  The spine division of Zimmer Biomet (NYSE ... will showcase its portfolio of innovative clinical solutions and ... meeting, October 14-17, 2015, in Chicago ... events: "Supplemental MIS Fixation Options for LLIF" ... 12:30 – 1 p.m. --> "Supplemental MIS ...
(Date:10/13/2015)...  Human Longevity, Inc. (HLI), the genomics-based, technology-driven company ... the launch of the company,s first Health Nucleus, a ... to transform healthcare. The inaugural Health Nucleus is located ... HLI,s headquarters facility. More Health Nucleus facilities are slated ... cities. --> --> ...
(Date:10/13/2015)... Oct. 13, 2015  Synapse Biomedical Inc. ( ... Study (PAS) studying the use of the NeuRx ® ... to enroll patients. the United States ... FDA market-approved criteria. The PAS study group met their ... The study has since expanded the enrollment target to ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... 13, 2015 , ... Element Blue ™, a leading ... company, RightSensor™ LLC, an Internet of Things (IoT) hardware supplier that delivers custom ... approach for customers requiring sensor hardware for critical data environments. , RightSensor™, working ...
(Date:10/13/2015)... CA (PRWEB) , ... October 13, 2015 , ... Dr. ... by Medical New Today on September 18, 2015. The research, which was conducted at ... Dr. Wael Sabbah and colleagues, show connections between stress during pregnancy and future dental ...
(Date:10/13/2015)... ... ... A child without a healthy mouth is much more likely to have an ... has joined with Global Dental Relief (GDR) to help bring dental care ... SmileCareClub will donate one clinic visit to a child in Kenya. , “When SmileCareClub ...
(Date:10/13/2015)... ... October 13, 2015 , ... Altec ... their Title Sponsorship of Synergy 2015. The annual WennSoft KEY2ACT user conference will ... Ranch and will unite customers, partners, WennSoft team members and sponsors to facilitate ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... ... in McHenry County, Illinois with more than 59,000 emergency department visits per year, ... system (EDIS) from T-System, to help improve clinical, operational and financial outcomes. ...
Breaking Medicine News(10 mins):